{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:45:04Z","timestamp":1791121504138,"version":"4.1.0"},"reference-count":200,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10,1]]},"DOI":"10.1093\/europace\/euq350","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T23:08:37Z","timestamp":1285715317000},"page":"1360-1420","source":"Crossref","is-referenced-by-count":1029,"title":["Guidelines for the management of atrial fibrillation"],"prefix":"10.1093","volume":"12","author":[{"name":"Developed with the special contribution of the European Heart Rhythm Association (EHRA)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Authors\/Task Force Members","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Camm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Schotten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Savelieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle C.","family":"Van Gelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawwar","family":"Al-Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Hindricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein","family":"Heidbuchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Atar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Colonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"De Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Goette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Gorenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Heldal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.","family":"Hohloser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Kolh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Le Heuzey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Committee for Practice Guidelines (CPG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Vahanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Auricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ceconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Funck-Brentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan A.","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Sechtem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Anton","family":"Sirnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Tendera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos E.","family":"Vardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Widimsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Scientific Document Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos E.","family":"Vardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vazha","family":"Agladze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Aliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tosho","family":"Balabanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Blomstrom-Lundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Capucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Dahl\u00f6f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Folliguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Glikson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marnix","family":"Goethals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich C.","family":"Gulba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Yen","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J. M.","family":"Klautz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedat","family":"Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Perrone Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Raatikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jesus","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Schalij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Shpektor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Stepinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasso","family":"Uuetoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Zupan","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,10,1]]},"reference":[{"key":"2026081001074860100_EUQ350C1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/heart.86.5.516","article-title":"Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew\/Paisley study","volume":"86","author":"Stewart","year":"2001","journal-title":"Heart"},{"key":"2026081001074860100_EUQ350C2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"2026081001074860100_EUQ350C3","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/eurheartj\/ehm358","article-title":"Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA)","volume":"28","author":"Kirchhof","year":"2007","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C4","first-page":"285","article-title":"A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project","volume":"47","author":"Lip","year":"1997","journal-title":"Br J Gen Pract"},{"key":"2026081001074860100_EUQ350C5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C7","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing prevalence of atrial fibrillation and flutter in the United States","volume":"104","author":"Naccarelli","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026081001074860100_EUQ350C8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"Stewart","year":"2002","journal-title":"Am J Med"},{"key":"2026081001074860100_EUQ350C10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C11","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/eurheartj\/ehn341","article-title":"Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy","volume":"29","author":"Knecht","year":"2008","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","article-title":"Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation","volume":"31","author":"Friberg","year":"2010","journal-title":"Eur Heart J"},{"issue":"448 e1\u2013e19","key":"2026081001074860100_EUQ350C13","article-title":"Quality of life in patients with atrial fibrillation: a systematic review","volume":"119","author":"Thrall","year":"2006","journal-title":"Am J Med"},{"key":"2026081001074860100_EUQ350C14","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/europace\/eun369","article-title":"The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management","volume":"11","author":"Nabauer","year":"2009","journal-title":"Europace"},{"key":"2026081001074860100_EUQ350C16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C17","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/eurheartj\/ehp046","article-title":"Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles","volume":"30","author":"Goette","year":"2009","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C18","article-title":"Pathophysiological mechanisms of atrial fibrillation\u2014a translational appraisal","author":"Schotten","year":"2010","journal-title":"Physiol Rev"},{"key":"2026081001074860100_EUQ350C19","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/01.CIR.94.7.1600","article-title":"Effect of atrial fibrillation on atrial refractoriness in humans","volume":"94","author":"Daoud","year":"1996","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","article-title":"Histological substrate of atrial biopsies in patients with lone atrial fibrillation","volume":"96","author":"Frustaci","year":"1997","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Haissaguerre","year":"1998","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C22","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1001\/jama.291.23.2851","article-title":"Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"2026081001074860100_EUQ350C23","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/eurheartj\/ehp235","article-title":"Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference \u2018Research perspectives in AF","volume":"30","author":"Kirchhof","year":"2009","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa0706300","article-title":"Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation","volume":"359","author":"Hodgson-Zingman","year":"2008","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jama.293.4.447","article-title":"Sodium channel mutations and susceptibility to heart failure and atrial fibrillation","volume":"293","author":"Olson","year":"2005","journal-title":"JAMA"},{"key":"2026081001074860100_EUQ350C26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1077771","article-title":"KCNQ1 gain-of-function mutation in familial atrial fibrillation","volume":"299","author":"Chen","year":"2003","journal-title":"Science"},{"key":"2026081001074860100_EUQ350C27","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/ng.417","article-title":"A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke","volume":"41","author":"Gudbjartsson","year":"2009","journal-title":"Nat Genet"},{"key":"2026081001074860100_EUQ350C28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0002-9149(86)90836-2","article-title":"Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction","volume":"57","author":"Packer","year":"1986","journal-title":"Am J Cardiol"},{"key":"2026081001074860100_EUQ350C29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"2026081001074860100_EUQ350C30","first-page":"1493","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias\u2014executive summary. a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society","volume":"42","author":"Blomstrom-Lundqvist","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C31","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta9400","article-title":"A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study","volume":"9","author":"Hobbs","year":"2005","journal-title":"Health Technol Assess"},{"key":"2026081001074860100_EUQ350C32","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/CIRCULATIONAHA.106.644484","article-title":"Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study","volume":"115","author":"Jahangir","year":"2007","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/europace\/eum120","article-title":"HRS\/EHRA\/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society","volume":"9","author":"Calkins","year":"2007","journal-title":"Europace"},{"key":"2026081001074860100_EUQ350C34","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/01.STR.0000131269.69502.d9","article-title":"Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack","volume":"35","author":"Jabaudon","year":"2004","journal-title":"Stroke"},{"key":"2026081001074860100_EUQ350C35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","article-title":"Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence","volume":"112","author":"Hindricks","year":"2005","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jacc.2003.08.027","article-title":"Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care","volume":"43","author":"Israel","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C37","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.hrthm.2006.07.030","article-title":"Comparison of continuous versus intermittent monitoring of atrial arrhythmias","volume":"3","author":"Ziegler","year":"2006","journal-title":"Heart Rhythm"},{"key":"2026081001074860100_EUQ350C38","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.109.874982","article-title":"Excessive Supraventricular ectopic activity and increased risk of atrial fibrillation and stroke","volume":"121","author":"Binici","year":"2010","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/europace\/eup097","article-title":"Indications for the use of diagnostic implantable and external ECG loop recorders","volume":"11","author":"Brignole","year":"2009","journal-title":"Europace"},{"key":"2026081001074860100_EUQ350C40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCEP.109.877852","article-title":"Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation\u2014results of the XPECT trial","volume":"3","author":"Hindricks","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026081001074860100_EUQ350C41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/CIRCEP.108.812347","article-title":"Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale","volume":"2","author":"Dorian","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026081001074860100_EUQ350C42","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","article-title":"Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"issue":"383","key":"2026081001074860100_EUQ350C43","article-title":"Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial","volume":"335","author":"Fitzmaurice","year":"2007","journal-title":"BMJ"},{"key":"2026081001074860100_EUQ350C44","first-page":"2388","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"29","author":"Dickstein","journal-title":"Eur Heart J 2008"},{"key":"2026081001074860100_EUQ350C45","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1053\/euhj.2000.2249","article-title":"The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology","volume":"21","author":"Haverkamp","year":"2000","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C46","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH07-08-0508","article-title":"Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data","volume":"99","author":"Hughes","year":"2008","journal-title":"Thromb Haemost"},{"key":"2026081001074860100_EUQ350C48","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1212\/01.wnl.0000267275.68538.8d","article-title":"Independent predictors of stroke in patients with atrial fibrillation: a systematic review","volume":"69","author":"Stroke in AF working group","year":"2007","journal-title":"Neurology"},{"key":"2026081001074860100_EUQ350C49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehn579","article-title":"Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications","volume":"30","author":"Schmitt","year":"2009","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C50","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"2026081001074860100_EUQ350C51","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"key":"2026081001074860100_EUQ350C52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2026081001074860100_EUQ350C53","article-title":"Identifying patients at risk of stroke despite anticoagulation","author":"Lip","year":"2010","journal-title":"Stroke"},{"key":"2026081001074860100_EUQ350C54","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"2026081001074860100_EUQ350C55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.STR.0000198839.61112.ee","article-title":"Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial","volume":"37","author":"Sato","year":"2006","journal-title":"Stroke"},{"key":"2026081001074860100_EUQ350C56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"2026081001074860100_EUQ350C57","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"2026081001074860100_EUQ350C58","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C59","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C60","doi-asserted-by":"crossref","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"2026081001074860100_EUQ350C61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1160\/TH09-08-0580","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary intervention\/stenting","volume":"103","author":"Lip","year":"2010","journal-title":"Thromb Haemost"},{"key":"2026081001074860100_EUQ350C62","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"546S\u2013592S","key":"2026081001074860100_EUQ350C63","article-title":"Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Singer","year":"2008","journal-title":"Chest"},{"key":"2026081001074860100_EUQ350C64","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/eurheartj\/ehl428","article-title":"Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology","volume":"28","author":"Vahanian","year":"2007","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C65","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1532-5415.2006.00828.x","article-title":"Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study","volume":"54","author":"Fang","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"2026081001074860100_EUQ350C66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/EJA.0b013e328334c017","article-title":"Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA)","volume":"27","author":"Poldermans","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"2026081001074860100_EUQ350C67","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","article-title":"Outpatient treatment of recent-onset atrial fibrillation with the \u2018pill-in-the-pocket\u2019 approach","volume":"351","author":"Alboni","year":"2004","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C68","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCEP.109.870204","article-title":"Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial","volume":"2","author":"Kowey","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026081001074860100_EUQ350C69","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.107.723866","article-title":"Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial","volume":"117","author":"Roy","year":"2008","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C70","article-title":"A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent onset atrial fibrillation","author":"Camm","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C71","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ehj.2004.04.030","article-title":"Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset","volume":"25","author":"Reisinger","year":"2004","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C72","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0735-1097(00)01116-5","article-title":"Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation","volume":"37","author":"Khan","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C73","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0002-9149(00)01128-0","article-title":"Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm","volume":"86","author":"Martinez-Marcos","year":"2000","journal-title":"Am J Cardiol"},{"key":"2026081001074860100_EUQ350C74","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0735-1097(02)02705-5","article-title":"Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis","volume":"41","author":"Chevalier","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C75","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1378\/chest.117.6.1538","article-title":"Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study","volume":"117","author":"Vardas","year":"2000","journal-title":"Chest"},{"key":"2026081001074860100_EUQ350C76","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1053\/euhj.1999.2039","article-title":"Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study","volume":"21","author":"Bianconi","year":"2000","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C77","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1161\/01.CIR.96.12.4298","article-title":"Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy","volume":"96","author":"Stambler","year":"1997","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C78","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(02)11315-8","article-title":"Anterior\u2013posterior versus anterior\u2013lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial","volume":"360","author":"Kirchhof","year":"2002","journal-title":"Lancet"},{"key":"2026081001074860100_EUQ350C79","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJM199906173402401","article-title":"Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment","volume":"340","author":"Oral","year":"1999","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1024203824761","article-title":"Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study","volume":"17","author":"Manios","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026081001074860100_EUQ350C81","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0735-1097(96)00230-6","article-title":"Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study","volume":"28","author":"Bianconi","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C82","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.CIR.65.2.348","article-title":"Acceleration of the ventricular response during atrial fibrillation in the Wolff\u2013Parkinson\u2013White syndrome after verapamil","volume":"65","author":"Gulamhusein","year":"1982","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C83","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ehj.2004.04.015","article-title":"Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial","volume":"25","author":"Fetsch","year":"2004","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C84","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/europace\/eum276","article-title":"Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode","volume":"10","author":"Cosio","year":"2008","journal-title":"Europace"},{"issue":"72","key":"2026081001074860100_EUQ350C85","article-title":"Can we improve outcomes in atrial fibrillation patients by early therapy?","volume":"7","author":"Kirchhof","year":"2009","journal-title":"BMC Med"},{"key":"2026081001074860100_EUQ350C86","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"AFFIRM Investigators","year":"2002","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C87","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C88","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0735-1097(03)00332-2","article-title":"Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation","volume":"41","author":"Carlsson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C89","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.126.2.476","article-title":"Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study","volume":"126","author":"Opolski","year":"2004","journal-title":"Chest"},{"key":"2026081001074860100_EUQ350C90","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C91","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1253\/circj.CJ-08-0608","article-title":"Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study","volume":"73","author":"Ogawa","year":"2009","journal-title":"Circ J"},{"key":"2026081001074860100_EUQ350C92","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","article-title":"Rhythm or rate control in atrial fibrillation\u2014Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial","volume":"356","author":"Hohnloser","year":"2000","journal-title":"Lancet"},{"key":"2026081001074860100_EUQ350C93","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMoa041018","article-title":"Catheter ablation for atrial fibrillation in congestive heart failure","volume":"351","author":"Hsu","year":"2004","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C94","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa0708234","article-title":"Pulmonary-vein isolation for atrial fibrillation in patients with heart failure","volume":"359","author":"Khan","year":"2008","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C95","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C96","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"key":"2026081001074860100_EUQ350C97","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.jacc.2010.01.023","article-title":"Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation","volume":"55","author":"Talajic","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C98","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C99","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C100","first-page":"47","article-title":"The evidence regarding the drugs used for ventricular rate control","volume":"49","author":"Segal","year":"2000","journal-title":"J Fam Pract"},{"key":"2026081001074860100_EUQ350C101","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.eurheartj.a060945","article-title":"Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study","volume":"16","author":"Hou","year":"1995","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C102","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1517\/14656566.6.6.955","article-title":"Use of medications in Wolff\u2013Parkinson\u2013White syndrome","volume":"6","author":"Redfearn","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"527.e1\u2013527.e9","key":"2026081001074860100_EUQ350C103","article-title":"Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study","volume":"156","author":"Davy","year":"2008","journal-title":"Am Heart J"},{"key":"2026081001074860100_EUQ350C104","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/01.CIR.99.21.2765","article-title":"Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation","volume":"99","author":"Murgatroyd","year":"1999","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C105","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/eurheartj\/ehn133","article-title":"Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation","volume":"29","author":"Gasparini","year":"2008","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C106","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM200104053441403","article-title":"Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation","volume":"344","author":"Ozcan","year":"2001","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C107","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0735-1097(03)00338-3","article-title":"The Australian intervention randomized control of rate in atrial fibrillation trial (AIRCRAFT)","volume":"41","author":"Weerasooriya","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C108","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2008.06.043","article-title":"Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies","volume":"52","author":"Upadhyay","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C109","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.amjcard.2006.07.087","article-title":"Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy","volume":"99","author":"Auricchio","year":"2007","journal-title":"Am J Cardiol"},{"key":"2026081001074860100_EUQ350C110","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2010.02.011","article-title":"Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy","author":"Dong","year":"2010","journal-title":"Heart Rhythm"},{"key":"2026081001074860100_EUQ350C111","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005049.pub2","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"4","author":"Lafuente-Lafuente","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2026081001074860100_EUQ350C112","article-title":"Management of new onset atrial fibrillation (evidence report\/Technology assessment)","author":"McNamara","year":"2001","journal-title":"Agency for Heathcare Research and Quality"},{"key":"2026081001074860100_EUQ350C113","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.100.19.2025","article-title":"Evidence-based analysis of amiodarone efficacy and safety","volume":"100","author":"Connolly","year":"1999","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C114","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jacc.2009.03.043","article-title":"Giant T\u2013U waves precede torsades de pointes in long QT syndrome. A systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation","volume":"54","author":"Kirchhof","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0195-668X(02)00806-0","article-title":"Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome-a case-control pilot study using i.v. sotalol","volume":"24","author":"K\u00e4\u00e4b","year":"2003","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C116","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8167.2010.01764.x","article-title":"A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study","volume":"21","author":"Le Heuzey","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026081001074860100_EUQ350C117","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C118","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/oxfordjournals.eurheartj.a062498","article-title":"Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study","volume":"9","author":"Karlson","year":"1988","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C119","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00823592","article-title":"Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group","volume":"10","author":"Crijns","year":"1996","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026081001074860100_EUQ350C120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C121","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jacc.2009.04.085","article-title":"Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation","volume":"54","author":"Piccini","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C122","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jacc.2009.10.071","article-title":"Dronedarone for atrial fibrillation: have we expanded the antiarrhythmic armamentarium","volume":"55","author":"Singh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C123","first-page":"S691","article-title":"Morbidity and mortality associated with anti-arrhythmic drugs in atrial fibrillation: a systematic review and mixed treatment meta-analysis (abstract)","volume":"120","author":"Freemantle","year":"2009","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C124","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C125","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators","volume":"342","author":"Roy","year":"2000","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure","volume":"333","author":"Singh","year":"1995","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C127","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0002-9149(89)90574-2","article-title":"Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter","volume":"64","author":"Van Gelder","year":"1989","journal-title":"Am J Cardiol"},{"key":"2026081001074860100_EUQ350C128","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1540-8167.2008.01101.x","article-title":"Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence","volume":"19","author":"Shah","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026081001074860100_EUQ350C129","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.CIR.0000157153.30978.67","article-title":"Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation","volume":"111","author":"Cappato","year":"2005","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C130","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jacc.2009.02.022","article-title":"Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation","volume":"53","author":"Cappato","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C131","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026081001074860100_EUQ350C132","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archinte.168.6.581","article-title":"Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review","volume":"168","author":"Noheria","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026081001074860100_EUQ350C133","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study","volume":"118","author":"Jais","year":"2008","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C134","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"key":"2026081001074860100_EUQ350C135","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.jacc.2006.08.037","article-title":"A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study","volume":"48","author":"Pappone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C136","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/europace\/eun104","article-title":"Consensus document on antithrombotic therapy in the setting of electrophysiological procedures","volume":"10","author":"Blanc","year":"2008","journal-title":"Europace"},{"key":"2026081001074860100_EUQ350C137","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/CIRCEP.109.856633","article-title":"Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials","volume":"2","author":"Piccini","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026081001074860100_EUQ350C138","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1540-8167.2008.01285.x","article-title":"A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation","volume":"20","author":"Nair","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026081001074860100_EUQ350C139","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.athoracsur.2007.04.036","article-title":"Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified?","volume":"84","author":"Ngaage","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"2026081001074860100_EUQ350C140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/01.CIR.0000151310.00337.FA","article-title":"Linear cryoablation of the left atrium versus pulmonary vein cryoisolation in patients with permanent atrial fibrillation and valvular heart disease: correlation of electroanatomic mapping and long-term clinical results","volume":"111","author":"Gaita","year":"2005","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C141","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/jama.1991.03470140088029","article-title":"Successful surgical treatment of atrial fibrillation. Review and clinical update","volume":"266","author":"Cox","year":"1991","journal-title":"JAMA"},{"key":"2026081001074860100_EUQ350C142","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1023\/A:1021184324825","article-title":"Surgical approaches to atrial fibrillation","volume":"6","author":"Gaita","year":"2002","journal-title":"Card Electrophysiol Rev"},{"key":"2026081001074860100_EUQ350C143","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ahj.2007.05.008","article-title":"Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?","volume":"154","author":"Savelieva","year":"2007","journal-title":"Am Heart J"},{"key":"2026081001074860100_EUQ350C144","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0735-1097(00)00611-2","article-title":"Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation","volume":"35","author":"Goette","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C145","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by renin\u2013angiotensin system inhibition a meta-analysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C146","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C147","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MJT.0b013e31804beb59","article-title":"Prevention of atrial fibrillation by way of abrogation of the renin\u2013angiotensin system: a systematic review and meta-analysis","volume":"15","author":"Jibrini","year":"2008","journal-title":"Am J Ther"},{"key":"2026081001074860100_EUQ350C148","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ahj.2006.01.007","article-title":"Meta-analysis: inhibition of renin\u2013angiotensin system prevents new-onset atrial fibrillation","volume":"152","author":"Anand","year":"2006","journal-title":"Am Heart J"},{"key":"2026081001074860100_EUQ350C149","first-page":"985","article-title":"Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"151","author":"Ducharme","year":"2006","journal-title":"Am Heart J"},{"key":"2026081001074860100_EUQ350C150","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C151","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/HJH.0b013e3282f35c67","article-title":"Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial","volume":"26","author":"Schmieder","year":"2008","journal-title":"J Hypertens"},{"key":"2026081001074860100_EUQ350C152","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/01.CIR.0000022665.18619.83","article-title":"Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study","volume":"106","author":"Madrid","year":"2002","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C153","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.ehj.2003.08.014","article-title":"Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study","volume":"24","author":"Ueng","year":"2003","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C154","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.amjcard.2007.01.030","article-title":"Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation","volume":"99","author":"Tveit","year":"2007","journal-title":"Am J Cardiol"},{"key":"2026081001074860100_EUQ350C155","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/eurheartj\/ehl135","article-title":"Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation","volume":"27","author":"Yin","year":"2006","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C156","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jacc.2008.08.071","article-title":"Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients","volume":"53","author":"Belluzzi","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C157","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa0805710","article-title":"Valsartan for prevention of recurrent atrial fibrillation","volume":"360","author":"Disertori","year":"2009","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C158","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ncpcardio1038","article-title":"Statins and polyunsaturated fatty acids for treatment of atrial fibrillation","volume":"5","author":"Savelieva","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2026081001074860100_EUQ350C159","first-page":"1","article-title":"Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance","volume":"381","author":"Savelieva","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2026081001074860100_EUQ350C160","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/europace\/euq044","article-title":"Usefulness of statins in preventing atrial fibrillation in patients with permanent pacemaker: a systematic review","volume":"12","author":"Santangeli","year":"2010","journal-title":"Europace"},{"key":"2026081001074860100_EUQ350C161","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/CIRCULATIONAHA.106.621763","article-title":"Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study","volume":"114","author":"Patti","year":"2006","journal-title":"Circulation"},{"issue":"678\u2013686 e1","key":"2026081001074860100_EUQ350C162","article-title":"Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review","volume":"138","author":"Liakopoulos","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026081001074860100_EUQ350C163","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehp006","article-title":"Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study","volume":"30","author":"Almroth","year":"2009","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C164","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jacc.2007.09.063","article-title":"Antiarrhythmic effect of statin therapy and atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"51","author":"Fauchier","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2007.07.137","article-title":"Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies","volume":"126","author":"Liu","year":"2008","journal-title":"Int J Cardiol"},{"key":"2026081001074860100_EUQ350C166","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/CIRCEP.109.899633","article-title":"Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial","volume":"3","author":"Saravanan","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026081001074860100_EUQ350C167","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/europace\/eup429","article-title":"Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?","volume":"12","author":"Heidarsdottir","year":"2010","journal-title":"Europace"},{"key":"2026081001074860100_EUQ350C168","doi-asserted-by":"crossref","DOI":"10.1093\/eurjhf\/hfq126","article-title":"Prediction of atrial fibrillation in patients with implantable cardioverter-defibrillator and heart failure","author":"Bertini","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026081001074860100_EUQ350C169","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amjcard.2008.09.064","article-title":"Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure","volume":"103","author":"Fauchier","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026081001074860100_EUQ350C170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/eurheartj\/ehl484","article-title":"Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis","volume":"28","author":"Nasr","year":"2007","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C171","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jacc.2003.07.020","article-title":"Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?","volume":"42","author":"Khand","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C172","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0735-1097(98)00561-0","article-title":"Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens","volume":"33","author":"Farshi","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2026081001074860100_EUQ350C173","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00007611-199608000-00005","article-title":"Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function","volume":"89","author":"Kumar","year":"1996","journal-title":"South Med J"},{"key":"2026081001074860100_EUQ350C174","doi-asserted-by":"crossref","first-page":"v82","DOI":"10.1093\/europace\/eup273","article-title":"Cardiac resynchronization therapy in heart failure patients with atrial fibrillation","volume":"11","author":"Gasparini","year":"2009","journal-title":"Europace"},{"key":"2026081001074860100_EUQ350C175","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/01.CIR.98.23.2574","article-title":"Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators","volume":"98","author":"Deedwania","year":"1998","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C176","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/hrt.2008.158931","article-title":"A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study)","volume":"95","author":"Shelton","year":"2009","journal-title":"Heart"},{"key":"2026081001074860100_EUQ350C177","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.amjcard.2009.01.374","article-title":"Relation of vigorous exercise to risk of atrial fibrillation","volume":"103","author":"Aizer","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026081001074860100_EUQ350C178","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCULATIONAHA.108.785626","article-title":"Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study","volume":"118","author":"Mozaffarian","year":"2008","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C179","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/euhj.2001.2802","article-title":"Long-lasting sport practice and lone atrial fibrillation","volume":"23","author":"Mont","year":"2002","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijcard.2005.02.043","article-title":"Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutter","volume":"107","author":"Heidbuchel","year":"2006","journal-title":"Int J Cardiol"},{"key":"2026081001074860100_EUQ350C181","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.hjr.0000239465.26132.29","article-title":"Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: supraventricular arrhythmias and pacemakers","volume":"13","author":"Heidbuchel","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2026081001074860100_EUQ350C182","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/europace\/eup320","article-title":"Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes","volume":"12","author":"Calvo","year":"2010","journal-title":"Europace"},{"key":"2026081001074860100_EUQ350C183","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10840-008-9329-8","article-title":"Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation","volume":"25","author":"Wyse","year":"2009","journal-title":"J Interv Card Electrophysiol"},{"key":"2026081001074860100_EUQ350C184","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1471-0528.1978.tb14909.x","article-title":"Propranolol for the treatment of hypertension in pregnancy","volume":"85","author":"Eliahou","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"key":"2026081001074860100_EUQ350C185","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"key":"2026081001074860100_EUQ350C186","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003611.pub2","article-title":"Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery","volume":"4","author":"Crystal","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"2026081001074860100_EUQ350C187","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/eurheartj\/ehl272","article-title":"Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis","volume":"27","author":"Burgess","year":"2006","journal-title":"Eur Heart J"},{"key":"2026081001074860100_EUQ350C188","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.athoracsur.2006.06.032","article-title":"Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis","volume":"82","author":"Bagshaw","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2026081001074860100_EUQ350C189","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2146\/ajhp050454","article-title":"Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis","volume":"63","author":"Patel","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"2026081001074860100_EUQ350C190","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1592\/phco.27.3.360","article-title":"Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation","volume":"27","author":"Buckley","year":"2007","journal-title":"Pharmacotherapy"},{"key":"2026081001074860100_EUQ350C191","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/hrt.2004.033811","article-title":"Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis","volume":"91","author":"Miller","year":"2005","journal-title":"Heart"},{"key":"2026081001074860100_EUQ350C192","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1161\/CIRCULATIONAHA.108.848218","article-title":"Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose\u2013response meta-analysis","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C193","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1540-8167.2003.02371.x","article-title":"Temporary atrial epicardial pacing as prophylaxis against atrial fibrillation after heart surgery: a meta-analysis","volume":"14","author":"Daoud","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026081001074860100_EUQ350C194","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ejcts.2006.09.003","article-title":"Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery","volume":"30","author":"Dunning","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026081001074860100_EUQ350C195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0733-8651(03)00136-X","article-title":"Management of atrial fibrillation in the post-cardiac surgery setting","volume":"22","author":"Daoud","year":"2004","journal-title":"Cardiol Clin"},{"key":"2026081001074860100_EUQ350C196","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/jama.291.14.1720","article-title":"A multicenter risk index for atrial fibrillation after cardiac surgery","volume":"291","author":"Mathew","year":"2004","journal-title":"JAMA"},{"key":"2026081001074860100_EUQ350C197","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1161\/CIRCULATIONAHA.104.483321","article-title":"Should catheter ablation be performed in asymptomatic patients with Wolff\u2013Parkinson\u2013White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff\u2013Parkinson\u2013White electrocardiogram","volume":"112","author":"Wellens","year":"2005","journal-title":"Circulation"},{"key":"2026081001074860100_EUQ350C198","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa035345","article-title":"A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff\u2013Parkinson\u2013White syndrome","volume":"349","author":"Pappone","year":"2003","journal-title":"N Engl J Med"},{"key":"2026081001074860100_EUQ350C199","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjcard.2003.10.025","article-title":"Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy","volume":"93","author":"Chen","year":"2004","journal-title":"Am J Cardiol"},{"key":"2026081001074860100_EUQ350C200","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J Am Coll Cardiol"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/12\/10\/1360\/70586450\/europace_12_10_1360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/12\/10\/1360\/70586450\/europace_12_10_1360.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T05:12:08Z","timestamp":1786338728000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/12\/10\/1360\/420757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,1]]},"references-count":200,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euq350","relation":{},"ISSN":["1532-2092","1099-5129"],"issn-type":[{"value":"1532-2092","type":"electronic"},{"value":"1099-5129","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,10]]},"published":{"date-parts":[[2010,10,1]]}}}